U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07110766) titled 'Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight' on July 23.
Brief Summary: This is a 12 weeks, multicenter, randomized, double-blind, placebo, parallel-controlled Phase Ib trail comparing the efficacy and safety of MDR-001 tablet versus placebo as an adjunct to a reduced calorie diet and increased physical activity in subjects with overweight or obesity, and to explore the optimal dose selection to support the subsequent Pivotal trial.
Study Start Date: Aug. 09
Study Type: INTERVENTIONAL
Condition:
Obesity &Amp; Overweight
Intervention:
DRUG: MDR-001
Oral administration ...